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LRRC8/VRAC anion channels enhance β-cell
glucose sensing and insulin secretion
Till Stuhlmann1,2, Rosa Planells-Cases1 & Thomas J. Jentsch 1,3
Glucose homeostasis depends critically on insulin that is secreted by pancreatic β-cells.
Serum glucose, which is directly sensed by β-cells, stimulates depolarization- and Ca2+-
dependent exocytosis of insulin granules. Here we show that pancreatic islets prominently
express LRRC8A and LRRC8D, subunits of volume-regulated VRAC anion channels. Hypo-
tonicity- or glucose-induced β-cell swelling elicits canonical LRRC8A-dependent VRAC cur-
rents that depolarize β-cells to an extent that causes electrical excitation. Glucose-induced
excitation and Ca2+ responses are delayed in onset, but not abolished, in β-cells lacking the
essential VRAC subunit LRRC8A. Whereas Lrrc8a disruption does not affect tolbutamide- or
high-K+-induced insulin secretion from pancreatic islets, it reduces first-phase glucose-
induced insulin secretion. Mice lacking VRAC in β-cells have normal resting serum glucose
levels but impaired glucose tolerance. We propose that opening of LRRC8/VRAC channels
increases glucose sensitivity and insulin secretion of β-cells synergistically with KATP closure.
Neurotransmitter-permeable LRRC8D-containing VRACs might have additional roles in
autocrine/paracrine signaling within islets.
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Insulin, the only hormone that lowers blood glucose con-centrations, is produced and secreted by pancreatic β-cellsthat constitute about 75% of the islets of Langerhans. Failure
to secrete sufficient amounts of insulin results in diabetes
mellitus, a common pathology with serious long-term compli-
cations that affect several tissues. A rise in serum glucose cell
autonomously stimulates β-cell insulin secretion1. Glucose
sensing by β-cells involves glucose transporter-mediated cel-
lular uptake of glucose and its conversion to ATP and other
metabolites. The rise in ATP inhibits KATP channels (ATP-
sensitive potassium channels) expressed in the plasma mem-
brane of β-cells. Since these channels largely control their
resting potential, KATP closure depolarizes β-cells and thereby
opens voltage-dependent Ca2+ channels. The resulting rise in
cytoplasmic calcium triggers exocytosis of insulin-containing
granules2.
The KATP-dependent mechanism for glucose-stimulated insu-
lin secretion is well established, not least by phenotypes resulting
from loss- and gain-of-function mutations in either component
(Kir6.2 (encoded by KCNJ11) and SUR1 (encoded by ABCC8)) of
the β-cell KATP channel2. However, there may be additional signal
transduction cascades controlling insulin secretion3, as deduced
e.g. from glucose-induced insulin secretion in SUR1 or
Kir6.2 knock-out (KO) mice4–6. Not only the inhibition of
K+ channels, but also the opening of Cl− channels may depo-
larize β-cells3,7–9. Opening of Cl− channels leads to a depolariz-
ing Cl− efflux because β-cells accumulate Cl− above
equilibrium9–12 using Na+K+2Cl− cotransporters13,14.
It has been proposed that the volume-regulated anion channel
VRAC contributes to insulin secretion by depolarizing β-cells in
response to glucose-induced cell swelling7,15. VRACs (also known
as VSOR or VSOAC) appear to be ubiquitously expressed in
vertebrate cells. They mediate volume-activated ICl,vol anion
currents that are crucial for regulatory volume decrease (RVD)
after hypotonic cell swelling16,17. Swelling of pancreatic β-cells
indeed induces ICl,vol-like currents18, but the reported Cl− > I−
selectivity of those currents19,20 differs from canonical VRAC17.
Since the molecular composition of VRAC has been enigmatic
until recently21, attempts to demonstrate a role of VRAC in
β-cells were based on notoriously non-specific inhibitors22–24
precluding conclusive evidence for an involvement of VRAC in
glucose sensing or insulin secretion.
We recently identified LRRC8 heteromers as the molecular
correlate of VRAC25. LRRC8A is the only essential subunit25,26,
but needs at least one of the other LRRC8 (leucine-rich repeat
containing 8) isoforms (LRRC8B,-C,-D or -E) to form volume-
regulated plasma membrane channels25. The LRRC8 subunit
composition determines not only biophysical properties of
VRAC such as inactivation and single-channel con-
ductance25,27,28, but more importantly its substrate specifi-
city29,30. For instance, VRACs containing LRRC8A and -D
subunits conduct various organic compounds including taurine,
neurotransmitters, and other signaling molecules29,30, suggesting
the intriguing possibility that VRAC has a role in paracrine or
autocrine signaling.
We now generated a mouse model in which we disrupted the
essential VRAC subunit LRRC8A specifically in pancreatic
β-cells. β-cell swelling, induced by hypotonicity or glucose,
activates canonical, LRRC8A-dependent ICl,vol currents that
depolarize the cell. Glucose-induced intracellular Ca2+ responses
are markedly delayed, but not abolished, in VRAC-deficient β-
cells. First-phase glucose-induced insulin secretion by LRRC8A-
deficient islets is reduced in vitro, and impaired glucose tolerance
of β-cell-specific Lrrc8a KO mice suggests an important
modulatory role of VRAC in insulin secretion in vivo.
Results
Expression and ablation of LRRC8/VRAC channels in β-cells.
To analyze the role of volume-regulated VRAC anion channels in
β-cell function and serum glucose regulation, we generated mice
in which the essential VRAC subunit LRRC8A25,26 was specifi-
cally deleted in pancreatic β-cells. Lrrc8alox/lox mice, in which
protein-coding exon 3 is flanked by loxP sites (Supplementary
Fig. 1), were crossed with Ins-Cre mice that express the Cre-
recombinase under the control of the rat insulin 2 promoter31.
The resulting Lrrc8alox/lox;Ins-Cre mice (subsequently named
βc-Δ8a mice for simplicity) were viable and lacked an overt
phenotype.
Western blot analysis revealed that whole pancreas and
purified islets expressed all five VRAC subunits (LRRC8A
through LRRC8E) (Fig. 1a). In comparison to whole pancreas,
however, islets had very little LRRC8E, but expressed larger
amounts of LRRC8A, -C and -D (Fig. 1a). For comparison,
human pancreatic islets express all LRRC8 subunits as
determined by single-cell transcriptome profiling32. Although
these data are difficult to compare, human LRRC8E appears
less expressed in islets compared to exocrine pancreas as found
here for mice, but human LRRC8C or -D expression does
not seem to differ greatly between islets and acinar/ductal
cells32. Since we lacked antibodies suitable for detecting
LRRC8 subunits in immunohistochemistry, we used knock-in
mice expressing an epitope-tagged version of LRRC8D under its
endogenous promoter to explore its presence in islets. LRRC8D,
which is crucial for VRAC’s ability to transport organic
compounds29,30, was strongly expressed in insulin-containing
β-cells (Fig. 1b, top). Immunolabeling of LRRC8D-tdTomato
stained not only the plasma membrane, but also prominently
the cytoplasm of these cells (Fig. 1b). However, we cannot
be sure whether this represents a significant presence of native
LRRC8D-containing VRACs in intracellular organelles, or
rather may have been caused by the fusion of the large epitope
to the LRRC8D carboxy-terminus. LRRC8D was also found,
albeit at apparently lower levels, in glucagon-secreting α-cells
(Fig. 1b, bottom). Consistent with the large preponderance of
exocrine over endocrine tissue, pancreatic expression levels of
LRRC8A appeared unchanged between control (Lrrc8alox/lox)
and βc-Δ8a mice (Fig. 1c). By contrast, LRRC8A protein levels
were markedly decreased in βc-Δ8a islets (Fig. 1c). The
magnitude of this decrease (~65%) was roughly compatible
with a complete disruption of Lrrc8a in β-cells (constituting
~75% of rodent islets33) if all islet cells express similar
amounts of LRRC8A. Indeed, lacZ staining of islets from mice
expressing β-galactosidase under the control of the Lrrc8a
promoter (Fig. 1d) suggested that all islet cells express similar
levels of LRRC8A.
Islet morphology of adult βc-Δ8a mice appeared normal
(Fig. 1e) and immunohistochemistry did not reveal changes in
insulin or glucagon expression (Fig. 1f). Western blot of
pancreas extracts suggested similar insulin levels (Fig. 1c), a
finding confirmed by ELISA analysis (Fig. 1g). β-cell-specific
disruption of LRRC8A neither changed total pancreatic (Fig. 1h)
nor β-cell mass (Fig. 1i). We neither detected changes in the
abundance of Kir6.2 (Fig. 1c), the ion-conducting α-subunit of
the pivotal KATP channel, nor did we detect signs for
inflammation or increased activated caspase in βc-Δ8a pancreas
(Supplementary Fig. 2). Hence neither developmental or
degenerative changes, nor indications for altered KATP-
dependent glucose signaling were detected in βc-Δ8a pancreas.
Moreover, βc-Δ8a mice showed no increased lethality during
our observation period of 30 weeks and their weight developed
normally during that time (Fig. 1j).
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Hypotonicity and glucose elicit LRRC8/VRAC currents in β-
cells. Exposure of both control (Lrrc8alox/lox) and βc-Δ8a β-cells
to a hypotonic solution led to similar levels of cell swelling, but β-
cells with disrupted Lrrc8a lacked the typical slow RVD that was
visible in control cells (Fig. 2a). Whole-cell patch-clamp record-
ings from control β-cells revealed the slow development of out-
wardly rectifying Cl− currents (ICl,vol) upon exposure to
hypotonic medium (Fig. 2b). These currents were almost com-
pletely blocked by 20 µM DCPIB, a potent, but non-specific
inhibitor of VRACs34–37 (Fig. 2b) and were absent from βc-Δ8a
β-cells (Fig. 2c–e). As described previously19,20,23, these currents
displayed only weak inactivation at positive potentials (Fig. 2d), a
finding we can now attribute to the relatively low expression of
the inactivation-promoting subunit LRRC8E25,28 in islets
(Fig. 1a). Two previous reports stated that ICl,vol of β-cells displays
a Cl− > I− selectivity19,20. This fueled speculation that the β-cell
channel differs from canonical VRAC38. Since the strict depen-
dence of ICl,vol on LRRC8A now identified the channel as
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Fig. 1 LRRC8 proteins in the pancreas and normal islet morphology upon β-cell-specific Lrrc8a disruption. a Western blot detection of the five VRAC
subunits LRRC8A, -B, -C, -D, and –E in lysates of purified islets of Langerhans (left lanes) or total pancreas (right) from wild-type mice. β-actin, loading
control. Arrowheads highlight specific bands as determined by previous knock-out controls. b Immunofluorescent detection (green) of LRRC8D in
pancreatic sections from knock-in mice expressing a LRRC8D-tdTomato fusion protein, co-stained (in red) for insulin (above) or glucagon (below). Left
panels, individual channels; right panels, overlays, with co-localization yielding yellow. Note that β-cells express much more LRRC8D than the surrounding
tissue. c Western blot of lysates from total pancreas or purified islets probed for LRRC8A, insulin, Kir6.2 (KATP channel subunit) from Lrrc8alox/lox mice
lacking Cre expression (−) or expressing Cre specifically in β-cells (+). β-actin, loading control. Right bottom, quantification of LRRC8A expression in
pancreatic islets normalized to Lrrc8lox/lox control. N= 3 independent experiments. Error bars, mean ± SEM. **P < 0.01 (Student’s t-test). d Lrrc8a
promoter-driven β-gal expression (X-gal staining, blue dots) in islets. Dotted lines highlight islets of Langerhans, insets higher magnification of boxed area.
Cells co-stained with eosin Y (pink). e Hematoxylin/eosin (H&E) stained formalin-fixed pancreatic sections of control (Lrrc8alox/lox) or βc-Δ8a mice
(lacking LRRC8A in β-cells). f Immunofluorescent staining of pancreatic islets of Lrrc8alox/lox and βc-Δ8a animals for insulin (green) and glucagon (red),
respectively. g Insulin levels of whole pancreas lysates normalized to control (Lrrc8alox/lox). h Pancreatic mass of Lrrc8alox/lox and βc-Δ8a animals
determined as ratio of organ to body weight. i β-cell mass as defined as ratio of insulin-positive cell area to complete pancreatic tissue area, multiplied by
pancreatic weight. j Body weight of Lrrc8alox/lox (black bars) and βc-Δ8a animals (white bars) at 3, 10 and 30 weeks of age. g–j Mean values ± SEM are
shown. Differences between genotypes are not significant in unpaired t-test: g p= 0.185, n= 7; h p= 0.609, n= 3; i p= 0.968, n= 6. j p= 0.086 at
3 weeks, p= 0.05 at 10 weeks, and p= 0.214 at 30 weeks, n= 16 (Lrrc8alox/lox), n= 11 (βc-Δ8a). Scale bars in b: 10 µm, in d–f: 50 µm
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04353-y ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1974 | DOI: 10.1038/s41467-018-04353-y |www.nature.com/naturecommunications 3
canonical VRAC (i.e., as LRRC8 channel), we re-investigated this
issue (Fig. 2f) and found that β-cell ICl,vol displays the I− > Cl−
selectivity that is typical for VRACs17,25,39.
Exposure of β-cells to high extracellular glucose also activates
an outwardly rectifying Cl− current, which shares several
characteristics with ICl,vol19,20,23. This activation has been
tentatively attributed to β-cell swelling that is observed after
exposure to high extracellular glucose15,40 and that may be caused
by osmotic effects of intracellular glucose metabolites7,40–42.
Indeed, when increasing the glucose concentration of the isotonic
superfusate from 3 to 25 mM, cell swelling was observed in both
Lrrc8alox/lox and βc-Δ8a β-cells (Fig. 3a). The extent of swelling
was smaller than with large changes of extracellular osmolarity
(Fig. 2a) and did not differ significantly between the genotypes.
Exposure to 20 mM glucose elicited typical outwardly rectifying,
slightly inactivating and DCPIB-sensitive currents in control
β-cells (Fig. 3b, c) that were abolished in βc-Δ8a cells (Fig. 3c, d).
Hence both hypotonicity- and glucose-induced β-cell currents are
mediated by swelling-activated LRRC8/VRAC channels.
Loss of LRRC8A reduces glucose response of β-cells. We next
investigated the impact of VRAC on β-cell excitation using the
perforated patch-clamp technique in the current clamp mode (at
I= 0). This allows recordings of the membrane potential with
minimal effects on cellular metabolism or ion concentrations.
Consistent with VRAC being closed at resting conditions17,39
(Fig. 2b), the resting membrane potential did not differ between
Lrrc8alox/lox and βc-Δ8a β-cells, neither at 1 nor at 5 mM external
glucose (Fig. 4a). When exposed to external hypotonicity (220
mOsm), β-cells from Lrrc8alox/lox, but not from βc-Δ8a mice,
slowly depolarized (Fig. 4b–d), presumably by an efflux of Cl−
through LRRC8 channels, which activate under these conditions
with a similarly slow time course (Fig. 2b). This depolarization
was more pronounced at 5 mM (Fig. 4b, c) than at 1 mM glucose
(Fig. 4e, f). This difference can be explained by a partial inhibition
of KATP at 5 mM glucose. Although not sufficient to significantly
depolarize β-cells when VRAC is closed or absent (in βc-Δ8a
cells) (Fig. 4a), this inhibition reduces the hyperpolarizing
K+ current that opposes the depolarizing Cl− current through
VRAC. In a sizeable fraction of Lrrc8alox/lox, but not βc-Δ8a
β-cells, hypotonicity elicited membrane potential spiking
(Fig. 4g, h).
Increasing external glucose concentration from 1 to 15 mM
induced action potentials in both Lrrc8alox/lox and βc-Δ8a β-cells
(Fig. 5a, b). However, cells devoid of VRAC needed on average
~100 s longer to reach the spiking threshold, although this
difference was not statistically significant with our sample size
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Fig. 2 Hypotonicity-induced cell swelling and VRAC currents in mouse β-cells. a Cell volume as monitored in individual β-cells using calcein fluorescence.
The extracellular isotonic solution was replaced by a 30% hypotonic solution (210mOsm) during the time indicated by the bar. Averaged curves ± SEM
(dotted lines), n= 16 and n= 18 for Lrrc8alox/lox and βc-Δ8a β-cells, respectively. Data are representative of three independent experiments. b
Representative time course of ICl,vol of an isolated primary β-cell provoked by superfusion with hypotonic solution (240mOsm) without or with 20 µM
DCPIB as indicated. Currents elicited at −80 to 80mV by voltage ramps (see c) are plotted. c Typical current-voltage (I–V) curves of hypotonicity-
provoked ICl,vol elicited by the ramp protocol shown below, from indicated genotypes and conditions. d Representative current traces obtained with the
voltage step protocol shown at bottom. The upper traces show control (Lrrc8lox/lox) currents after full activation of ICl,vol, taken at the time indicated by
arrow in b. Even at +100mV, β-cell ICl,vol only slightly inactivates. The lower traces are from a βc-Δ8a β-cell exposed for 15 min to hypotonicity. e ICl,vol
current densities at−80 mV of Lrrc8alox/lox and βc-Δ8a β-cells under iso- and hypotonic conditions. Mean values ± SEM; ***p < 0.0005 (one-way ANOVA,
Tukey’s test); number of cells given in bars; iso: isotonic solution (310mOsm), hypo: hypotonic solution (240mOsm). f Ion selectivity of β-cell ICl,vol.
Example traces (from the same cell) obtained with the ramp protocol after maximal ICl,vol activation, in the presence of extracellular chloride (black trace)
or iodide (green trace). The shifts of reversal potentials Erev with I− to more negative values indicated a permeability ratio pI−/pCl−= 1.44 ± 0.06 (n= 6)
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(Fig. 5c). The frequency and amplitude of glucose-induced action
potentials were unchanged (Fig. 5d). β-cells began to spike before
they depolarized to the degree observed with hypotonicity (Fig. 4),
presumably because the increased membrane resistance caused by
partial KATP closure renders the positive feedback between
voltage-dependent Na+- and Ca2+-channel opening and depo-
larization more efficient. In contrast to glucose, which requires
cellular uptake and metabolism to exert its inhibitory and
stimulatory effects on KATP and VRAC, respectively, the KATP
inhibitor tolbutamide almost instantly elicited β-cell spiking that
was indistinguishable between the genotypes (Fig. 5a, b, e). This
agrees with unchanged Kir6.2 protein expression (Fig. 1c) and
suggests that the activity of this pivotal channel is not affected by
the loss of VRAC. As another read-out for β-cell stimulation, we
determined the rise of intracellular Ca2+ ([Ca2+]i), the final
trigger for insulin exocytosis. Mirroring the effect on β-cell
excitability, 15 mM glucose increased [Ca2+]i in both genotypes,
but with a significantly longer delay in βc-Δ8a cells (Fig. 5f–h). A
tendency for a delayed glucose response of Lrrc8a−/− β-cells
became already apparent in the 6–8 mM glucose concentration
range (Supplementary Fig. 3). The peak Ca2+-response, however,
did not differ significantly between the genotypes (Fig. 5i). To
investigate whether VRAC influences β-cell excitability beyond
the initial 15 min investigated so far, we studied the effect of 10
mM glucose on Ca2+ oscillations of intact islets that were
preincubated for 30 min with this glucose concentration before
starting the measurements. Islets from both genotypes showed the
typical range of Ca2+ oscillation patterns43 (Supplementary
Fig. 4), with no obvious difference between the genotypes. To
conclude, although VRAC is not required for glucose to excite β-
cells, it increases their glucose sensitivity during the early phase of
glucose stimulation.
Lrrc8a disruption reduces insulin secretion. We next asked
whether VRAC modulates insulin secretion. Supernatants from
single islets from Lrrc8alox/lox and βc-Δ8a mice were collected 30
min after stimulation and their insulin content determined by
ELISA (Fig. 6a). There was no difference in insulin release
between the genotypes in the presence of 3.3 mM glucose.
Depolarization of β-cells by increasing [K+]o from 5 to 45 mM, or
by exposure to 300 µM tolbutamide, increased insulin secretion
about 15- and 5-fold, respectively, irrespective of the Lrrc8a
genotype. Increasing glucose concentration to 25 mM enhanced
insulin release about eightfold and sixfold with Lrrc8alox/lox and
βc-Δ8a islets, respectively. However, this apparent difference
failed to reach statistical significance (p= 0.11). A similar degree
of stimulation and borderline difference between the genotypes
(p= 0.08) was observed when islets were exposed to both 25 mM
glucose and 300 µM tolbutamide. The absence of a marked effect
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of VRAC ablation on insulin secretion agrees with the limited
effect on glucose-induced excitation and Ca2+-transients of β-
cells, which was apparent only in a 5–10 min time window
(Fig. 5c, f–h, Supplementary Fig. 3). Indeed, when measured only
within the first 8 min of adding 25 mM glucose, Lrrc8alox/lox islets
secreted about twice as much insulin than their βc-Δ8a coun-
terparts (p= 0.008) (Supplementary Fig. 5). However, these high
glucose concentrations are unlikely to be reached in vivo. We
therefore examined whether VRAC modulates insulin secretion
with more physiological glucose stimuli, which was suggested by
the effect of 15 mM (Fig. 5a–c, f–h) and possibly even lower
(Supplementary Fig. 3) glucose concentrations on β-cell excit-
ability. Indeed, a significant, roughly 50% decrease of insulin
secretion by βc-Δ8a islets in an 8 min time window was observed
also with 10 mM glucose (Fig. 6b). There was no difference in the
response to tolbutamide or high potassium under identical con-
ditions, confirming that canonical KATP signaling is not affected
(Fig. 6b). We finally tested whether the deletion of VRAC in β-
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potential of control Lrrc8alox/lox or βc-Δ8a β-cells at 1 or 5 mM glucose concentrations. Mean values ± SEM indicated by error bars. b Representative trace
for hypotonicity-induced depolarization of the membrane potential Vm in control Lrrc8alox/lox animals at 5 mM glucose. TOLB, tolbutamide. c ΔVm after
applying hypotonicity, or following washout with isotonic solution of Lrrc8alox/lox or βc-Δ8a cells at 5 mM glucose, calculated from data as indicated in b.
Spiking cells (see g and h) were excluded from analysis. d Representative voltage trace showing lack of hypotonicity-induced depolarization of βc-Δ8a β-
cells at 5 mM glucose. e ΔVm of Lrrc8alox/lox or βc-Δ8a cells as in c, but at 1 mM glucose. f Representative trace for Lrrc8alox/lox β-cells challenged with
hypotonicity in the presence of 1 mM glucose. g Percentage of cells responding with electrical activation following hypotonic stimulation. h Voltage trace of
an Lrrc8alox/lox β-cell responding with electrical activity to hypotonicity in the presence of 5 mM glucose. *p < 0.05, **p < 0.01 (one-way ANOVA, Tukey’s
test)
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cells affects the regulation of blood glucose in vivo. Whereas
serum concentrations of glucose were not different between the
genotypes (Lrrc8alox/lox, 163 ± 12 mg/dl; βc-Δ8a,162 ± 9 mg/dl; n
= 11), βc-Δ8a mice were abnormal in glucose tolerance assays
(Fig. 6c). Mice of both genotypes were injected intraperitoneally
with glucose solutions and their blood glucose levels were fol-
lowed over 2 h. Compared to Lrrc8alox/lox control mice, βc-Δ8a
mice displayed significantly higher serum glucose concentrations
30 and 60 min after the glucose load. By contrast, mice of either
genotype behaved similarly in insulin tolerance tests (Fig. 6d),
demonstrating that β-cell-specific disruption of VRAC, as
expected, does not influence peripheral glucose uptake. Impor-
tantly, Lrrc8a+/+; Ins-Cre+ and Lrrc8alox/lox; Ins-Cre− control
groups behaved indistinguishably in these assays, showing that a
reported interference of the Ins2-Cre construct itself44 is not of
concern here. Finally, glucose-stimulated insulin secretion in vivo
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Fig. 6 Effect of LRRC8A/VRAC disruption on insulin secretion in vitro and in vivo and on glucose tolerance. a Insulin release from single islets stimulated by
high glucose, tolbutamide, and potassium. Islets were incubated for 30min under the indicated conditions and insulin concentrations in the supernatant
were measured. Number of islets is indicated in bars (derived from 5 mice per genotype (25mM glc), 1 mouse per genotype (TOLB), 3 mice per genotype
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insulin levels at 2 min after glucose injection yields p= 0.07
Fig. 5 Glucose-induced electrical activity and intracellular Ca2+ response in Lrrc8alox/lox and βc-Δ8a cells. a, b Representative voltage traces for glucose-
and tolbutamide-induced electrical activity of control Lrrc8alox/lox (a) and βc-Δ8a (b) β-cells obtained with gramicidin-perforated patches in the current
clamp mode. Enlarged traces are shown in red boxes, with corresponding time periods indicated by boxes in the complete trace at left. c Percentage of
electrically active cells plotted against time after glucose application. The response of βc-Δ8a cells seemed delayed by about 100 s (dotted lines), but the
difference between genotypes failed to be statistically significant with 24 control and 18 βc-Δ8a β-cells. d Mean frequency and amplitude of spikes during
bursts of action potentials elicited by 15mM glucose. e Mean frequency and amplitude of spikes elicited by 300 µM tolbutamide. f Individual traces for
Fura-2 fluorescence ratios elicited by excitation at λ= 340 and 380 nm (indicative of [Ca2+]i). 15 mM glucose was added at t= 60 s. gMean ratio of Fura-
2 fluorescence over time. Time points at which differences between the two genotypes reached statistical significance are indicated. *p < 0.05, #p < 0.01
(two-way ANOVA, Bonferroni multiple comparisons); mean values ± SEM, 69 control and 71 βc-Δ8a β-cells. h Cumulative plot of cells that have reached
peak levels of [Ca2+]i after addition of 15 mM glucose as function of time. The difference is statistically significant (p= 0.005, Kolmogorov-Smirnov test). i
Peak value of calcium response of β-cells of both genotypes. The difference is not significant. Number of cells indicated in columns
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(Fig. 6e) suggested that early insulin secretion of βc-Δ8a mice is
impaired, agreeing with our results on β-cell excitability and
insulin secretion in vitro. Although, like in every gene disruption
experiment, we cannot totally exclude secondary effects, we
conclude that LRRC8/VRAC channels of β-cells modulate insulin
secretion and the regulation of blood glucose.
Discussion
Serum glucose concentration is subject to complex regulatory
mechanisms mainly involving glucose-mobilizing glucagon and
glucose-lowering insulin. These hormones are produced and
secreted by pancreatic islet α- and β-cells, respectively. Their
secretion is not only controlled by serum glucose, but also by
other hormones such as incretins, neurotransmitters, and para-
crine/autocrine mechanisms within the islet1,45–47. Glucose sen-
sing by β-cells crucially involves inhibition of KATP channels by
intracellular ATP/ADP ratios, which rise owing to increased
glucose uptake and metabolism2. Our work reveals an important
modulatory role of LRRC8/VRAC channels in β-cell stimulus-
secretion coupling. These chloride channels depolarize β-cells in
response to glucose-induced β-cell swelling, thereby enhancing
the glucose-induced increase in cytoplasmic Ca2+ and insulin
secretion. The presence of neurotransmitter-permeable LRRC8D-
containing VRACs in β-cells raises the possibility that they may
also be involved in autocrine and paracrine signaling in islets.
Evidence has accumulated over many years that ion channels
other than KATP may be involved in glucose-induced β-cell
depolarization and insulin secretion3. Prime candidates are Cl−
channels since their opening leads to a depolarizing Cl− efflux in
the presence of the high intracellular Cl− concentration of β-
cells11,13. Recently the cystic fibrosis transmembrane conductance
regulator CFTR has been implicated in modulating the glucose
response and insulin secretion of β-cells9. Together with the
destruction of pancreatic tissue in certain forms of the disease,
reduced CFTR-stimulated insulin secretion might contribute to
diabetes in some patients with cystic fibrosis. CFTR needs
intracellular ATP for gating, but it is unclear whether glucose-
induced increase in [ATP]i can account for the apparently
glucose-induced opening of this cAMP-gated channel. VRAC has
emerged as another attractive candidate for a Cl− channel that
modulates insulin secretion7. However, the anion selectivity
previously reported for ICl,vol in β-cells19,20 does not fit to cano-
nical VRAC/LRRC8 channels17,25,39,48 and the mystery sur-
rounding its molecular identity21,49 for a long time has precluded
conclusive studies both in vitro and in vivo.
We have now demonstrated conclusively that ICl,vol of β-cells is
mediated by LRRC8 channels, i.e., canonical VRACs displaying a
I− > Cl− selectivity. Opening LRRC8 channels by hypotonicity
can depolarize β-cells up to the threshold for action potential
firing. Although the extent of hypotonicity used in our experi-
ments is clearly non-physiological, these experiments provide
proof of principle that swelling-activation of LRRC8 channels can
depolarize β-cells to voltages that depend on the magnitude of
glucose-induced KATP inhibition. The situation is more complex
with exposure to high glucose. It both inhibits KATP channels by
the slow increase in ATP/ADP ratios, and slowly activates LRRC8
channels, probably by cell swelling that may be due to osmotic
effects of several glucose metabolites including lactate7,40,42.
Glucose activation of VRAC and inhibition of KATP have a similar
time course that is largely determined by the accumulation of
glucose metabolites. As shown by the delayed, but otherwise
normal response of βc-Δ8a cells to high glucose, VRAC is clearly
not required for glucose-induced excitation of β-cells, but mod-
ulates their glucose sensitivity. Accordingly a marked effect of
VRAC on insulin secretion was only observed at 8 min of glucose
addition to isolated islets. When sampled over 30 min, differences
in insulin secretion failed to reach significance levels. Importantly,
however, β-cell-specific disruption of VRAC led to significantly
impaired glucose tolerance and glucose-induced insulin secretion
appeared to be decreased in vivo.
While this manuscript was under review, Sah and coworkers
asserted50 that the LRRC8A subunit (renamed “SWELL1”) is a
“glucose sensor” required for glucose-induced excitation and
insulin secretion of β-cells. Both studies coincide in that VRAC
plays a role in glucose sensitivity of β-cells in vitro and in vivo
and agree in several other aspects. However, in stark contrast to
our study, Kang et al. reported that glucose-induced Ca2+ tran-
sients and insulin secretion were abolished in Lrrc8a−/− β-cells,
rather than only being delayed or decreased as found by us. The
suggested absolute requirement for VRAC50 is surprising in view
of the rather mild phenotypes of β-cell-specific Lrrc8a−/− mice
and unchanged resting glucose levels in either study, and also
because the major, canonical KATP pathway for glucose sensing
remains intact upon Lrrc8a disruption. Moreover, consistent with
VRAC being closed at rest, both studies reported that the resting
potential of Lrrc8a−/− β-cells is unchanged. This virtually elim-
inates the possibility that β-cell hyperpolarization counteracts the
depolarizing effect of KATP closure in Lrrc8a−/− mice. A possible
explanation for the discrepancy between both studies might
be found in methodological differences. Whereas we used β-cells
from βc-Δ8a mice, Kang et al.50 more acutely disrupted Lrrc8a
with adenoviral transduction of Cre-recombinase into Lrrc8alox/
lox cells, or alternatively reduced Lrrc8a expression by transduc-
tion of shRNA. Whereas in our study the lack of VRAC might
have been compensated by altered expression of other channels
(although the KATP pathway appeared unchanged), the acute viral
overexpression of either Cre-recombinase or shRNA by Kang
et al.50 might have caused secondary changes that further
decreased the glucose sensitivity of Lrrc8a−/− β-cells. Another
decisive factor may be the rather short exposure of β-cells to
glucose used by Kang et al.50, who thus may have missed the
delayed glucose response of KO cells found here.
Several aspects of β-cell LRRC8/VRAC channels need to be
considered. First, VRAC-dependent cell volume regulation is not
essential for the survival, development, and overall function of β-
cells, probably because cells dispose of several redundant
mechanisms for regulating their volume16. Importantly, β-cell-
specific Lrrc8a disruption did not affect pancreas and islet mor-
phology, β-cell mass, insulin content, Kir6.2 expression, the
response to tolbutamide, and did not cause inflammation. Hence
our results are unlikely to be influenced by developmental or
compensatory changes. Second, although VRAC needs basal
levels of ATP for channel activity17,51, it is not activated by
intracellular ATP. Glucose activation of VRAC is most likely
caused by osmotic cell swelling due to glucose metabolites7,40,42, a
notion that is bolstered by our study. Multiple mechanisms have
been proposed to explain volume-activation of VRAC17,49,
including a direct activation by low intracellular ionic
strength27,52,53. Third, VRAC might only have a transient role in
glucose-stimulated insulin secretion because its opening will lead
to an efflux of chloride and organic osmolytes such as taur-
ine25,54, resulting in RVD and a subsequent downregulation of
VRAC activity. Although we could not detect RVD in glucose-
swollen β-cells over a period of 12 min (Fig. 3a), which might be
owed to continued generation of intracellular glucose-derived
osmolytes, a transient role of VRAC in the initial response to
glucose is indeed suggested by our experiments (Fig. 5c, g, h,
Fig. 6a, b). Fourth, VRAC may play a role in autocrine and
paracrine signaling in pancreatic islets. LRRC8 channels not only
conduct chloride, but also organic compounds including osmo-
lytes, drugs, and neurotransmitters25,29,30,55. Transport of these
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compounds is determined by the LRRC8 subunit composi-
tion29,30. Intriguingly, LRRC8D, a subunit important for the
transport of all organic compounds tested so far29,30, shows much
stronger expression in islets than in whole pancreas (Fig. 1a) and
is abundantly expressed in β-cells (Fig. 1b). LRRC8D-containing
VRACs conduct, for instance, taurine29, an agonist of glycine and
GABA receptors56, GABA30, glycine57 and glutamate30. β-cells
express GABA-synthesizing glutamate decarboxylases58 and dis-
play sizeable cytoplasmic concentrations of GABA58–61. There-
fore, in addition to vesicular discharge12,46,62, neurotransmitters
and regulators might be released from β-cells through LRRC8/
VRAC channels. Both α- and β-cells express glycine and GABA
receptors12,61–63 that may influence glucose homeostasis by sti-
mulating β-cells in an autocrine fashion or by exerting a paracrine
effect on glucagon secretion by α-cells. In addition to the direct
depolarization by VRAC-mediated Cl− efflux, VRAC might
additionally influence systemic glucose homeostasis by autocrine/
paracrine effects within islets.
Methods
Animals. Animals were housed under standard conditions in the MDC animal
facility according to institutional guidelines. All animal experiments were approved
by German authorities (LAGeSo) in a letter to the MDC. Mice heterozygous for the
targeted Lrrc8a allele (Lrrc8atm2a(EUCOMM)Hmgu) were generated by injecting tar-
geted ES cells (obtained from EUCOMM (European Conditional Mouse Muta-
genesis Program) consortium) into blastocysts (MDC Transgenic Facility).
Lrrc8atm2a(EUCOMM)Hmgu animals were crossed to Cre- or Flp-recombinase
expressing deleter mice64,65 to generate two different Lrrc8a mouse models (Sup-
plementary Fig. 1). For β-cell-specific Lrrc8a deletion, Lrrc8alox/lox mice were
crossed to Ins2-Cre (Tg(Ins2-cre)23Herr) mice, which express the Cre-recombinase
under the control of the rat insulin2 promotor31. Ins2-Cre animals were also
crossed to Rosa26-Cre reporter line (B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J)
66 to verify cell-type specificity of Cre expression (Supplementary Fig. 6a).
Although the Ins2-Cre (Tg(Ins2-cre)23Herr) mouse expresses the recombinase also
in sparse cells scattered over the brain67,68, which we confirmed by crossing this
strain with reporter mice (Supplementary Fig. 6b), this is not a concern since Kang
et al.50 used the recommended Ins1CreERT2 strain to delete Lrrc8a and obtained
results in vivo similar to ours. Knock-in mice expressing an LRRC8D-tdTomato
fusion protein from the endogenous Lrrc8d promoter were generated by CRISPR-
Cas9 mediated recombination in fertilized mouse oocytes that were implanted into
foster mothers by the MDC Transgenic Facility. Sequence encoding the tdTomato
fluorescent protein69 was added to the carboxy-terminus of LRRC8D. Control
experiments indicated that the tag did not change the electrophysiological prop-
erties or expression of LRRC8D in transfected cells. The generation and char-
acterization of these mice will be described in detail elsewhere. The fluorescence of
the fusion protein was insufficient for detection in tissue sections, requiring
immunohistochemistry with anti-RFP-antibodies visualization of the fusion pro-
tein. All mice were in a C57/BL6 genetic background.
Antibodies and western blots. Rabbit polyclonal antibodies against individual
LRRC8 subunits had been generated in our laboratory and their specificity had
been confirmed in western blots using KO cell lines as controls as described25,29,30.
The following commercial antibodies were used: guinea pig anti-insulin (Dako,
A0564; 1:500), mouse anti-glucagon (Abcam, ab10988; 1:1000), mouse anti-β-actin
(Sigma, A2228; 1:2000), rabbit anti-RFP (Rockland, 600401379; 1:1000), rabbit
anti-Kir6.2 (Abgent, AG1143; 1:200), goat anti-NLRP3 (Lifespan Biosciences, LS-
B1766; 1:200), rabbit anti-active caspase 3 (Promega; G748A1; 1:400). Secondary
antibodies were from Molecular Probes (coupled to Alexa-488 or Alexa-555 or
Alexa 633), or from Jackson ImmunoResearch (coupled to horseradish peroxidase).
Quantification of western blots used ImageJ. LRRC8A levels were normalized to
actin controls on the same blot. Uncropped western blots are shown in Supple-
mentary Fig. 7.
Histology and immunohistochemistry. For histology, deeply anesthetized mice
were perfused with PBS, followed by PBS containing 4% paraformaldehyde (PFA).
Dissected pancreas were postfixed overnight in 4 % PFA, dehydrated in a graded
isopropanol series, and then incubated in isopropanol/paraffin (1:1) mixture
overnight at 65 °C. The tissue was embedded in paraffin and cut in 8 µm sections
which were stained with hematoxylin and eosin Y (H&E) according to standard
procedure. To prepare frozen tissue sections, tissue from perfused animals was
postfixed for 45 min in 4% PFA, incubated in 30% sucrose overnight at 4 °C, and
embedded in Tissue-Tek O.C.T. (Sakura). Frozen sections of 8 µm were cut using a
cryostat (Microm HM 560, Thermo Fisher Scientific). For X-Gal staining, sections
were first stained with eosin Y, washed in 0.1 M phosphate buffer (pH 7.4, con-
taining 2 mM MgCl2, 5 mM EGTA, 0.02% NP-40, 0.01% Na-deoxycholate), and
then incubated for 15 h at 37 °C in 0.1 M phosphate buffer (pH 7.4) containing X-
Gal 1 mg/ml, 2 mM MgCl2, 5 mM EGTA, 0.2% NP-40, 0.1% Na-deoxycholate, 5
mM K3Fe(CN)6, 5 mM K4Fe(CN)6. Images of H&E or X-Gal stainings were taken
with an AxioCam MRc 5 camera on an Axiophot microscope using the ZEN
software (all from Zeiss). Immunohistochemistry was performed on frozen tissue
sections permeabilized with 0.2% Triton X-100 in PBS, blocked for 30 min in
blocking buffer (PBS containing 0.1% Triton X-100, 3% BSA) and incubated
overnight at 4 °C with primary antibodies in blocking buffer. Sections were incu-
bated with secondary antibodies and counterstained with DAPI (Invitrogen) for 45
min at room temperature. Confocal images were taken with a Zeiss LSM 510
microscope using the ZEN software.
Islet purification and primary cell culture. Eight- to 18-week-old mice of either
sex were killed by cervical dislocation. The bile duct was clamped before inflating
the pancreas with HBSS. The inflated pancreas was dissected, cut into smaller
pieces and digested for 11 min at 37 °C using 15 ml HBSS containing 20 mg col-
lagenase from Clostridium histolyticum (Sigma, C9407–5G) with vigorous shaking
every 2 min. Digestion was stopped with ice-cold HBSS and islets were further
purified from exocrine tissue using a Histopaque gradient and centrifugation for
10 min at 800×g (Heraeus Multifuge 3 l). Histopaque 1119 (Sigma, 11191) was
diluted with HBSS to obtain solutions with different densities (1.119, 1.1, 1.108,
1.106 g/ml). Islets were transferred to RPMI 1640 and manually isolated under
microscopic control. Purified islets were incubated in RPMI 1640 (containing 10%
FCS, 1% pen/strep) at 37 °C and 5% CO2 overnight before performing further
experiments. Primary β-cell cultures were prepared by dispersing the purified islets
using an enzyme-free cell dissociation solution (Millipore, S-004-B) and cultured in
RPMI 1640 (10% FCS, 1% pen/strep). Single isolated β-cells were used for patch-
clamp and calcium measurement.
Insulin secretion in vitro. Single islets of similar size were transferred to a 96-well
plate and were subsequently incubated at 37 °C on a shaking platform (300 r.p.m.)
for 30 min each in solutions containing different stimuli. Afterwards islets were
lysed and released insulin was normalized to the total islet insulin content. Stan-
dard secretion buffer contained (in mM) 98 NaCl, 0.9 CaCl2, 2.7 KCl, 1.5 KH2PO4,
0.5 MgCl2, 8 Na2HPO4, 20 HEPES, 0.2% BSA, pH 7.4 with NaOH. Different
concentrations of glucose (3.3, 10 or 25 mM) or 300 µM tolbutamide were added
and the osmolarity of the solutions was balanced by adding mannitol (290 mOsm).
Islets that showed morphological changes indicative of lysis or cell death at the end
of the secretion period were excluded from the analysis. Islets were lysed afterwards
to normalize secreted insulin amounts to the total insulin content. Insulin levels in
the supernatant or from total pancreatic lysates were measured using an ultra-
sensitive insulin ELISA (Alpco, 80-INSMSU-E01) according to manufacturer’s
instructions. The genotype of islets was revealed only after the end of the
experiment.
Cytoplasmic Ca2+ measurements. Single β-cells or intact islets were seeded on
poly-L-lysine (PLL) coated glass bottom live-cell dishes 24 h before. Cells or islets
were washed with bath solution containing (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 2.5
CaCl, 20 HEPES, and 3 glucose (pH 7.4). Bath solution containing 6, 8, 10, or 15
mM glucose were used for stimulation and osmolarity of the solutions was com-
pensated by mannitol (290 mOsm). Cells or islets were loaded with Fura-2 AM
(Invitrogen) (5 µM) at 37 °C for 30 min. After washing with bath solution, live-cell
dishes were mounted on an Axiovert 200 microscope (Zeiss) and alternatively
excited at λ= 340 or 380 nm (Polychrome V TILL Photonics) while emission
signals were recorded at λ= 510 nm. The ratio of 340/380 fluorescence was cal-
culated and values were normalized to F0. Solutions containing 6, 8, or 15 mM
glucose were added after 60 s and the fluorescence was measured every 15 s. To
measure Ca2+ oscillations in intact islets, these were already stimulated with 10
mM glucose solution 30 min before the experiment. Ca2+ oscillations were mea-
sured in the continued presence of 10 mM glucose. Fura-2 fluorescence ratios were
measured every 3 s for 20 min.
Electrophysiology. Single β-cells, being bigger than other pancreatic cells, were
identified by their size and granular appearance and showed a membrane capa-
citance of >5 pF. They were cultured on PLL-coated coverslips 24–48 h before
recording. Whole-cell patch-clamp recordings were performed using isotonic
solution containing (in mM) 130 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2, 20 HEPES, 20
mannitol, pH 7.4 with NaOH (310 mOsm) or hypotonic solution containing (in
mM) 105 NaCl, 5 CsCl, 1 MgCl2, 2.5 CaCl2, 20 HEPES, pH 7.4 (240 mOsm). To
determine ion selectivity, 105 mM NaCl was substituted by 105 mM NaI. Glucose-
activated ICl,vol was measured in isotonic solution with 20 mM glucose substituting
mannitol (pH 7.4, 310 mOsm). The patch pipette solution contained (in mM) 100
CsCl, 20 tetraethylammonium-Cl, 10 HEPES, 4 MgATP, 5 EGTA, 1.93 CaCl2
(calculated free Ca2+: 50–100 nM), 25 mannitol (pH 7.2 with CsOH, 290 mOsm).
The holding potential was set to −30 mV. A ramp protocol from −80 to 80 mV
(Fig. 2b) was run every 15 s to record the time course of ICl,vol activation. Following
complete activation of ICl,vol, a step voltage protocol was applied (−80 to 100 mV in
20 mV steps every 5 s (Fig. 2c)). Relative anion permeability was calculated as
described25.
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Membrane potentials were measured by gramicidin-perforated patch-clamp
recordings in the current clamp mode (I= 0). The pipette solution contained (in
mM) 138 KCl, 10 NaCl, 1 MgCl2, 10 HEPES, pH 7.2 with KOH (290 mOsm) and
freshly added 25 µg/ml gramicidin (Sigma, G5002). Electrical access with a
resistance of <50MΩ was obtained after 5–15 min. Cells were superfused with
isotonic solutions containing (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2, 20
HEPES, pH 7.4 and different glucose (1, 5, or 15) concentrations, with osmolarity
adjusted to 290 mOsm with mannitol. Hypotonic solutions contained 90 NaCl, 5
KCl, 1 MgCl2, 2.5 CaCl2, 20 HEPES, pH 7.4 and different glucose (1 or 5)
concentrations (220 mOsm). All recordings were performed at room temperature.
We used an EPC-10 patch-clamp amplifier controlled with the PatchMaster
software (HEKA). Data were analyzed using the software pClamp 10.6 (Molecular
Devices). Patch pipettes were pulled to a resistance of 2–5MΩ.
β-cell mass and pancreatic mass. β-cell mass was calculated from immunohis-
tochemical stainings as the ratio of insulin-positive area to total pancreatic tissue
area, each of which was measured from three different tissue sections per animal
(two animals per genotype) using ImageJ and multiplied by the weight of the
organ. The relative pancreatic mass was measured as the ratio of the organ weight
to body weight.
Cell volume measurements of β cells. Cell volume measurements employed the
calcein method70. Cells were loaded with 4 µM calcein AM (Affymetrix eBios-
ciences) at 37 °C for 30 min. Live-cell dishes mounted on an Axiovert 200
microscope (Zeiss) were extensively washed with isosmotic solution. Cells were
recorded for 2 min in isosmotic solution (in mM: 90 NaCl; 1 MgCl2; 2 CaCl2; 10
glucose; 10 HEPES; 100 mannitol pH 7.4; 310 mOsm before switching to hypotonic
solution (210 mOsm), in which mannitol was omitted). For glucose stimulation
experiments, cells were superfused and recorded for a minimum of 5 min in 3 mM
glucose-containing isosmotic solution (same as used for cytoplasmic Ca2+ mea-
surements; 290 mOsm) and then exposed to 25 mM glucose-containing isosmotic
solution. Isotonicity of 3 and 25 mM glucose solutions was achieved with mannitol.
For recordings, fluorescence was excited at λ= 496 nm while emission signals were
recorded at λ= 510 nm (Polychrome V, TILL Photonics) and images acquired at
30 s intervals. Fluorescence of selected ROIs was measured. Data are presented as F
− F0 values, where F0 is the fluorescence in isosmotic solution at time 0, and F is
the fluorescence at time t.
In vivo experiments. Adult male mice were fasted for 4 h prior to intraperitoneal
injection of glucose (2 mg/g body weight). Blood was withdrawn from the tail and
glucose levels were measured with a blood glucose meter (Contour XT, Bayer) at
time points 0, 15, 30, 60, and 120 min post injection. Following a 48 h resting
period, the same animals used for the GTT were again injected intraperitoneally
with insulin (0.75 U/kg body weight) and blood glucose levels were measured as
described before. GSIS was performed at the Mouse Metabolic Evaluation Facility
(MEF) in Lausanne (Switzerland) according to their experimental design and
institutional guidelines. Animals were intraperitoneally injected with glucose (2
mg/g body weight) and blood was withdrawn from the tail vein 60 min before, as
well as 2 and 15 min after glucose injection. Plasma insulin levels were evaluated
using an insulin-ELISA. In all cases, the genotype of the animals was only revealed
after the completion of the experiment.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
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